CClinicalTrials.gg
TerminatedNCT05864820Updated Dec 10, 2024

Photogrammetric Scan System for Body Composition Analysis

An observational study in Anthropometry and Musculoskeletal System, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. Terminated at 1 site in Italy. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-10.

Sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Observational

Why this study was terminated
Inability to continue corporate collaboration for analysis for body composition analysis through photogrammetric scan system.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
75
Ages
18 Years to 85 Years
Sex
All
01

Study summary

This observational study evaluates the goodness of the IGOODI photogrammetric scan system in measuring anthropometry and estimating the body composition of 75 healthy subjects, comparing the results with the measurements taken using methods used in clinical practice, including body circumferences and bioimpedance analysis.

02

Conditions studied

  • Anthropometry
  • Musculoskeletal System
03

In context

Lead sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio is the lead sponsor of 157 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects of the general population

Inclusion criteria

  • Male or female gender
  • Between the ages of 18 and 85
  • Caucasian race
  • Cognitively intact
  • Acceptance and signing of informed consent
  • Height between 120 and 200 cm (included)

Exclusion criteria

Exclusion Criteria:

  • Congenital or acquired musculoskeletal deformities of the limbs or trunk
  • Implants resulting from cosmetic surgery
  • Articular prostheses and/or means of synthesis
  • Current oncological or metabolic pathologies
  • Photosensitivity
  • Epilepsy
  • Claustrophobia
  • Subjects unable to independently maintain an upright position
  • Wearers of pacemakers
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
75 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Correlation between anthropometric circumferences

    Association between the circumferences taken with clinical practice methodology (inelastic and flexible tape measure) and the results from the photogrammetric technology

    Time frame: Baseline and after 1 year

07

Study locations

1 site
  • IRCCS Istituto Ortopedico Galeazzi
    Milan, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05864820
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Responsible party
Sponsor
First posted
May 18, 2023
Start date
Apr 18, 2023
Primary completion
Jun 27, 2024
Completion
Jun 27, 2024
Last update
Dec 10, 2024

Study contacts

Matteo Briguglio
principal investigator · IRCCS Istituto Ortopedico Galeazzi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion